Please assess the completion status of the following clinical trial:

Trial Title: A Study to Assess the Efficacy, Safety and Tolerability of Pregabalin in Patients With Symptoms of Neuropathic Pain

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE3
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Chinese outpatient of age 18 to 75~* At screening and baseline, a score of greater than 40 mm on the visual log scale of SF-MPQ~Exclusion Criteria:~* Neurologic disorders unrelated to neuropathic pain, which in the opinion of the investigator, might impair the assessment of pain~* Serum creatinine clearance greater than 60 ml/min

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 75 Years
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).